Europe Gastrointestinal Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Route of Administration (Injectable and Oral & Others), By Application, By Drug Class, By Country and Growth Forecast, 2022 - 2028

The Europe Gastrointestinal Therapeutics Market would witness market growth of 3.2% CAGR during the forecast period (2022-2028).

Most gastrointestinal drugs are designed to act locally, reducing systemic absorption as much as possible. When a prescription is absorbed systemically at low levels, informative pharmacokinetic and pharmacodynamic (PK/PD) drug profiles are difficult to obtain and usually require simulation and modeling. High-quality PK analysis is critical for making substantive arguments regarding the exposure-response relationship.

The gastrointestinal (GI) tract is a 25-foot-long pathway that extends from the anus to the mouth. Everything one eats passes through the esophagus and gets processed in the small intestine and the stomach to absorb nutrients. Finally, the waste is removed from the body through the colon and rectum. Sometimes a tumor can form in one of these organs due to the change in the DNA that causes abnormal cells to grow.

According to the UK National Screening Committee, stomach cancer tends to affect people aged 55 and above. It was seen as more common in men than in women. Presently bacterial infection causes around 40% of stomach cancers. It was found that people under 50 are developing stomach cancer due to various other factors, such as being obese. The burden of gastrointestinal and liver disease is heavy for patients. The NHS, and the economy, stated the gastrointestinal illness as the third most common cause of death, the leading cause of cancer death, and the most common reason of admission in hospitals.

The Germany market dominated the Europe Gastrointestinal Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,924.4 million by 2028. The UK market is anticipated to grow at a CAGR of 2.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 3.9% during (2022 - 2028).

Based on Type, the market is segmented into Branded and Generics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Route of Administration, the market is segmented into Injectable and Oral & Others. Based on Application, the market is segmented into Crohn's Disease, Ulcerative Colitis, GERD, IBS and Others. Based on Drug Class, the market is segmented into Biologics/Biosimilar, Anti-Diarrheal, Anti-Emetics, Digestive Enzymes, Aminosalicylates, Proton Pump Inhibitors, Laxatives & H2 Antagonists and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Gastrointestinal Therapeutics Market will Hit $45.9 Billion by 2028, at a CAGR of 3.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, AbbVie, Inc., Takeda Pharmaceutical Company Limited, Pfizer, Inc., Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.), Johnson & Johnson (Janssen Global Services, LLC), AstraZeneca PLC, Bayer AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Branded
• Generics

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Route of Administration

• Injectable
• Oral & Others

By Application

• Crohn's Disease
• Ulcerative Colitis
• GERD
• IBS
• Others

By Drug Class

• Biologics/Biosimilar
• Anti-Diarrheal
• Anti-Emetics
• Digestive Enzymes
• Aminosalicylates
• Proton Pump Inhibitors
• Laxatives & H2 Antagonists
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• AbbVie, Inc.
• Takeda Pharmaceutical Company Limited
• Pfizer, Inc.
• Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
• Johnson & Johnson (Janssen Global Services, LLC)
• AstraZeneca PLC
• Bayer AG
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Gastrointestinal Therapeutics Market, by Type
1.4.2 Europe Gastrointestinal Therapeutics Market, by Distribution Channel
1.4.3 Europe Gastrointestinal Therapeutics Market, by Route of Administration
1.4.4 Europe Gastrointestinal Therapeutics Market, by Application
1.4.5 Europe Gastrointestinal Therapeutics Market, by Drug Class
1.4.6 Europe Gastrointestinal Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Gastrointestinal Therapeutics Market

Chapter 4. Europe Gastrointestinal Therapeutics Market by Type
4.1 Europe Branded Market by Country
4.2 Europe Generics Market by Country

Chapter 5. Europe Gastrointestinal Therapeutics Market by Distribution Channel
5.1 Europe Retail Pharmacies Market by Country
5.2 Europe Hospital Pharmacies Market by Country
5.3 Europe Online Pharmacies Market by Country

Chapter 6. Europe Gastrointestinal Therapeutics Market by Route of Administration
6.1 Europe Injectable Market by Country
6.2 Europe Oral & Others Market by Country

Chapter 7. Europe Gastrointestinal Therapeutics Market by Application
7.1 Europe Crohn's Disease Market by Country
7.2 Europe Ulcerative Colitis Market by Country
7.3 Europe GERD Market by Country
7.4 Europe IBS Market by Country
7.5 Europe Others Market by Country

Chapter 8. Europe Gastrointestinal Therapeutics Market by Drug Class
8.1 Europe Biologics/Biosimilar Market by Country
8.2 Europe Anti-Diarrheal Market by Country
8.3 Europe Anti-Emetics Market by Country
8.4 Europe Digestive Enzymes Market by Country
8.5 Europe Aminosalicylates Market by Country
8.6 Europe Proton Pump Inhibitors Market by Country
8.7 Europe Laxatives & H2 Antagonists Market by Country
8.8 Europe Others Market by Country

Chapter 9. Europe Gastrointestinal Therapeutics Market by Country
9.1 Germany Gastrointestinal Therapeutics Market
9.1.1 Germany Gastrointestinal Therapeutics Market by Type
9.1.2 Germany Gastrointestinal Therapeutics Market by Distribution Channel
9.1.3 Germany Gastrointestinal Therapeutics Market by Route of Administration
9.1.4 Germany Gastrointestinal Therapeutics Market by Application
9.1.5 Germany Gastrointestinal Therapeutics Market by Drug Class
9.2 UK Gastrointestinal Therapeutics Market
9.2.1 UK Gastrointestinal Therapeutics Market by Type
9.2.2 UK Gastrointestinal Therapeutics Market by Distribution Channel
9.2.3 UK Gastrointestinal Therapeutics Market by Route of Administration
9.2.4 UK Gastrointestinal Therapeutics Market by Application
9.2.5 UK Gastrointestinal Therapeutics Market by Drug Class
9.3 France Gastrointestinal Therapeutics Market
9.3.1 France Gastrointestinal Therapeutics Market by Type
9.3.2 France Gastrointestinal Therapeutics Market by Distribution Channel
9.3.3 France Gastrointestinal Therapeutics Market by Route of Administration
9.3.4 France Gastrointestinal Therapeutics Market by Application
9.3.5 France Gastrointestinal Therapeutics Market by Drug Class
9.4 Russia Gastrointestinal Therapeutics Market
9.4.1 Russia Gastrointestinal Therapeutics Market by Type
9.4.2 Russia Gastrointestinal Therapeutics Market by Distribution Channel
9.4.3 Russia Gastrointestinal Therapeutics Market by Route of Administration
9.4.4 Russia Gastrointestinal Therapeutics Market by Application
9.4.5 Russia Gastrointestinal Therapeutics Market by Drug Class
9.5 Spain Gastrointestinal Therapeutics Market
9.5.1 Spain Gastrointestinal Therapeutics Market by Type
9.5.2 Spain Gastrointestinal Therapeutics Market by Distribution Channel
9.5.3 Spain Gastrointestinal Therapeutics Market by Route of Administration
9.5.4 Spain Gastrointestinal Therapeutics Market by Application
9.5.5 Spain Gastrointestinal Therapeutics Market by Drug Class
9.6 Italy Gastrointestinal Therapeutics Market
9.6.1 Italy Gastrointestinal Therapeutics Market by Type
9.6.2 Italy Gastrointestinal Therapeutics Market by Distribution Channel
9.6.3 Italy Gastrointestinal Therapeutics Market by Route of Administration
9.6.4 Italy Gastrointestinal Therapeutics Market by Application
9.6.5 Italy Gastrointestinal Therapeutics Market by Drug Class
9.7 Rest of Europe Gastrointestinal Therapeutics Market
9.7.1 Rest of Europe Gastrointestinal Therapeutics Market by Type
9.7.2 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel
9.7.3 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration
9.7.4 Rest of Europe Gastrointestinal Therapeutics Market by Application
9.7.5 Rest of Europe Gastrointestinal Therapeutics Market by Drug Class

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 AbbVie, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Approvals and Trials:
10.3 Takeda Pharmaceutical Company Limited
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisition and Mergers:
10.4 Pfizer, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.5 Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.6 Johnson & Johnson (Janssen Global Services, LLC)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental &Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 AstraZeneca PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.8 Bayer AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 Sun Pharmaceutical Industries Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.10. Cipla Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense

TABLE 1 Europe Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Europe Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Europe Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 Europe Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 Europe Branded Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Branded Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Generics Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Generics Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 10 Europe Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 11 Europe Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 18 Europe Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 19 Europe Injectable Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Injectable Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Oral & Others Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Oral & Others Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 Europe Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 Europe Crohn's Disease Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Crohn's Disease Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Ulcerative Colitis Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Ulcerative Colitis Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe GERD Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe GERD Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe IBS Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe IBS Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 36 Europe Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 37 Europe Biologics/Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Biologics/Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Anti-Diarrheal Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Anti-Diarrheal Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Anti-Emetics Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe Anti-Emetics Market by Country, 2022 - 2028, USD Million
TABLE 43 Europe Digestive Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe Digestive Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 45 Europe Aminosalicylates Market by Country, 2018 - 2021, USD Million
TABLE 46 Europe Aminosalicylates Market by Country, 2022 - 2028, USD Million
TABLE 47 Europe Proton Pump Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 48 Europe Proton Pump Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 49 Europe Laxatives & H2 Antagonists Market by Country, 2018 - 2021, USD Million
TABLE 50 Europe Laxatives & H2 Antagonists Market by Country, 2022 - 2028, USD Million
TABLE 51 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 52 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 53 Europe Gastrointestinal Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 54 Europe Gastrointestinal Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 55 Germany Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 56 Germany Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 57 Germany Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 58 Germany Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 59 Germany Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 Germany Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Germany Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 62 Germany Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 63 Germany Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 64 Germany Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 65 Germany Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 66 Germany Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 67 UK Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 68 UK Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 69 UK Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 70 UK Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 71 UK Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 72 UK Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 73 UK Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 UK Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 UK Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 76 UK Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 77 UK Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 78 UK Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 79 France Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 80 France Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 81 France Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 82 France Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 83 France Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 France Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 France Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 86 France Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 87 France Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 88 France Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 89 France Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 90 France Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 91 Russia Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 92 Russia Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 93 Russia Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 94 Russia Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 95 Russia Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 96 Russia Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 97 Russia Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 98 Russia Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 99 Russia Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 100 Russia Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 101 Russia Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 102 Russia Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 103 Spain Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 104 Spain Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 105 Spain Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 106 Spain Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 107 Spain Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 108 Spain Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 109 Spain Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 110 Spain Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 111 Spain Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 112 Spain Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 113 Spain Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 114 Spain Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 115 Italy Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 116 Italy Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 117 Italy Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 118 Italy Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 119 Italy Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 120 Italy Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 121 Italy Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 122 Italy Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 123 Italy Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 124 Italy Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 125 Italy Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 126 Italy Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 127 Rest of Europe Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 128 Rest of Europe Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 129 Rest of Europe Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 130 Rest of Europe Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 131 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 132 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 133 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 134 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 135 Rest of Europe Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 136 Rest of Europe Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 137 Rest of Europe Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 138 Rest of Europe Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 139 Key Information – Abbott Laboratories
TABLE 140 Key information – AbbVie, Inc.
TABLE 141 Key Information – Takeda Pharmaceutical Company Limited
TABLE 142 Key Information – Pfizer, Inc.
TABLE 143 key information – Salix Pharmaceuticals, Inc.
TABLE 144 Key information –Johnson & Johnson
TABLE 145 KEY INFORMATION – AstraZeneca PLC
TABLE 146 Key Information – Bayer AG
TABLE 147 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 148 Key Information – Cipla Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories
FIG 3 Recent strategies and developments: Takeda Pharmaceutical Company Limited